Antiepileptic drugs for bipolar disorder and the risk of suicidal behavior: A 30-year observational study

American Journal of Psychiatry

Volumn 169, Issue 3, 2012, Pages 285-291

  Leon, Andrew C ^a,b,c,d,e   Solomon, David A ^a,b,c,d,e   Li, Chunshan ^a,b,c,d,e   Fiedorowicz, Jess G ^a,b,c,d,e   Coryell, William H ^a,b,c,d,e   Endicott, Jean ^a,b,c,d,e   Keller, Martin B ^a,b,c,d,e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BROWN UNIVERSITY   (United States)

^c UpToDate Inc   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DEMOGRAPHY; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT PARTICIPATION; PRIORITY JOURNAL; PROPENSITY SCORE; PROSPECTIVE STUDY; SCHIZOAFFECTIVE PSYCHOSIS; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT; SURVIVAL TIME; UNITED STATES; UNIVERSITY HOSPITAL;

EID: 84858993442     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2011.11060948     Document Type: Article

References (39)

1. Christensen J, Vestergaard M, Mortensen PB, Sidenius P, Agerbo E: Epilepsy and risk of suicide: a population-based case-control study. Lancet Neurol 2007; 6:693-698 (Pubitemid 47058376)
2. Nilsson L, Ahlbom A, Farahmand BY, Asberg M, Tomson T: Risk factors in suicide in epilepsy: a case-control study. Epilepsia 2002; 43:644-651 (Pubitemid 34627725)
3. Ratcliffe GE, Enns MW, Belik SL, Sareen J: Chronic pain conditions and suicidal ideation and suicide attempts: an epidemiologic perspective. Clin J Pain 2008; 24:204-210 (Pubitemid 351640917)
4. Tsai SY, Kuo CJ, Chen CC, Lee HC: Risk factors for completed suicide in bipolar disorder. J Clin Psychiatry 2002; 63:469-476
5. Simon GE, Hunkeler E, Fireman B, Lee JY, Savarino J: Risk of suicide attempt and suicide death in patients treated for bipolar disorder. Bipolar Disord 2007; 9:526-530 (Pubitemid 47202516)
6. US Food and Drug Administration: FDA Alerts Health Care Providers to Risk of Suicidal Thoughts and Behavior With Anti-epileptic Medications. Jan 31, 2008. http://www.fda.gov/Drugs/ DrugSafety/ PostmarketDrugSafetyInformationforPatientsand- Providers/ucm100200.htm
7. US Food and Drug Administration: Statistical Review and Evaluation: Antiepileptic Drugs and Suicidality. May 23, 2008. http:// www.fda.gov/ohrms/ dockets/ac/08/briefing/2008-4372b1-01- FDA.pdf
8. US Food and Drug Administration: Antiepileptic Drugs and Suicidality. May 5, 2009. http://www.fda.gov/CDER/Drug/infopage /antiepileptics/default.htm
9. US Food and Drug Administration: Labeling Change Request Letter for Antidepressant Medications, 2004. http://www.fda. gov/Drugs/DrugSafety/ InformationbyDrugClass/ucm096352. htm
10. US Food and Drug Administration: Labeling Template for Antidepressant Medications, 2005. http://www.fda.gov/cder/drug/antidepressants/default.htm
11. Katz MM, Klerman GL: Introduction: overview of the clinical studies program (NIMH Clinical Research Branch Collaborative Study on Psychobiology of Depression). Am J Psychiatry 1979; 136:49-51
12. Spitzer RL, Endicott J, Robins E: Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978; 35:773-782 (Pubitemid 9064061)
13. Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H: Recurrence of bipolar disorders and major depression: a life-long perspective. Eur Arch Psychiatry Clin Neurosci 2003; 253:236-240 (Pubitemid 37203960)
14. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, Lavori P, Lebowitz B, Rudorfer M, Frank E, Nierenberg AA, Fava M, Bowden C, Ketter T, Marangell L, Calabrese J, Kupfer D, Rosenbaum JF: Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2003; 53:1028-1042 (Pubitemid 36645233)
15. Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, Kupka RW, Keck PE Jr, Leverich GS, Post RM: Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry 2004; 161:1447-1454 (Pubitemid 38989099)
16. Endicott J, Spitzer RL: A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1978; 35:837-844 (Pubitemid 9076798)
17. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald- Scott P, Andreasen NC: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44:540-548 (Pubitemid 17082095)
18. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D: Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290:1467-1473 (Pubitemid 37430401)
19. Collins JC, McFarland BH: Divalproex, lithium, and suicide among Medicaid patients with bipolar disorder. J Affect Disord 2008; 107:23-28 (Pubitemid 351297777)
20. Hedeker D, Siddiqui O, Hu FB: Random-effects regression analysis of correlated grouped-time survival data. Stat Methods Med Res 2000; 9:161-179 (Pubitemid 30623558)
21. Rosenbaum P, Rubin DB: The central role of the propensity score in observational studies for causal effects. Biometrika 1983; 70:41-55
22. Gu X, Rosenbaum PR: Comparison of multivariate matching methods: structures, distances, and algorithms. J Comput Graph Stat 1993; 2:405-420
23. Hansen BB: Full matching in an observational study of coaching for the SAT. J Am Stat Assoc 2004; 99:609-618
24. Hansen BB, Klopfer SO: Optimal Full Matching and Related Designs V ia Network Flows (Technical Report 416). Department of Statistics, University of Michigan, Ann Arbor, 2005
25. Leon AC, Solomon DA, Mueller TI, Endicott J, Rice JP, Maser JD, Coryell W, Keller MB: A 20-year longitudinal observational study of somatic antidepressant treatment effectiveness. Am J Psychiatry 2003; 160:727-733 (Pubitemid 41079606)
26. Leon AC, Solomon DA, Li C, Fiedorowicz JG, Coryell WH, Endicott J, Keller MB: Antidepressants and risks of suicide and suicide attempts: a 27-year observational study. J Clin Psychiatry 2011; 72:580-586
27. Leon AC, Hedeker D, Teres JJ: Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment. Stat Med 2007; 26:110-123 (Pubitemid 46099420)
28. Kleyman Y, Hansen B: Basic Uses of the OptMatch Package. 2005. http://w w w.stat.lsa.umich.edu/~bbh/optmatch/doc / optmatch.pdf
29. Hansen BB, Fredrickson M: OptMatch package, version 0.7-1. http://cran.r-project.org/web/packages/optmatch/index.html
30. Hedeker D, Gibbons RD: Longitudinal Data Analysis. Hoboken, NJ, John Wiley & Sons, 2006
31. Hedeker D, Gibbons RD, Du Toit SHC, Patterson D: SuperMix: A Program for Mixed-Effects Regression Models. Chicago, Scientific Software International, 2008
32. Endicott J, Cohen J, Nee J, Fleiss J, Sarantakos S: Hamilton Depression Rating Scale: extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia. Arch Gen Psychiatry 1981; 38:98-103 (Pubitemid 11156718)
33. Leon AC: Comparative effectiveness clinical trials in psychiatry: superiority, noninferiority, and the role of active comparators. J Clin Psychiatry 2011; 72:1344-1349
34. Wenzel A, Berchick ER, Tenhave T, Halberstadt S, Brown GK, Beck AT: Predictors of suicide relative to other deaths in patients with suicide attempts and suicide ideation: a 30-year prospective study. J Affect Disord 2011; 132:375-382
35. Gibbons RD, Hur K, Brown CH, Mann JJ: Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009; 66:1354-1360
36. Arana A, Wentworth CE, Ayuso-Mateos JL, Arellano FM: Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010; 363:542-551
37. Redden L, Pritchett Y, Robieson W, Kovacs X, Garofalo M, Tracy K, Saltarelli M: Suicidality and divalproex sodium: analysis of controlled studies in multiple indications. Ann Gen Psychiatry 2011; 10:1
38. Drake C: Effects of misspecification of the propensity score on estimators of the treatment effect. Biometrics 1993; 49:1231-1236
39. Leon AC, Hedeker D: Quintile stratification based on a mis-specified propensity score in longitudinal treatment effectiveness analyses of ordinal doses. Comput Stat Data Anal 2007; 51:6114-6122 (Pubitemid 47126009)